Htg Molecular Diagnostics, Inc financial data

Location
3430 E. Global Loop, Tucson, AZ
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2023 - May 11, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 173 % -51.7%
Quick Ratio 16.4 % -36.4%
Debt-to-equity 410 % +197%
Return On Equity -638 % -366%
Return On Assets -125 % -118%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.21M shares -70.8%
Common Stock, Shares, Outstanding 2.21M shares -74.2%
Common Stock, Value, Issued 2.21K USD -74.2%
Weighted Average Number of Shares Outstanding, Basic 2.21M shares +232%
Weighted Average Number of Shares Outstanding, Diluted 2.21M shares +232%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.21M USD -28.2%
Research and Development Expense 6.47M USD -2.46%
Costs and Expenses 25.8M USD -8.35%
Operating Income (Loss) -19.6M USD -0.47%
Nonoperating Income (Expense) -551K USD -176%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -20.1M USD -7.27%
Income Tax Expense (Benefit) 12.7K USD -37.9%
Net Income (Loss) Attributable to Parent -20.2M USD -7.22%
Earnings Per Share, Basic -17 USD/shares +76.6%
Earnings Per Share, Diluted -17 USD/shares +76.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3M USD -79.5%
Accounts Receivable, after Allowance for Credit Loss, Current 1.13M USD +51.1%
Inventory, Net 655K USD -67.6%
Assets, Current 9.19M USD -63.9%
Property, Plant and Equipment, Net 529K USD -43.9%
Operating Lease, Right-of-Use Asset 893K USD -28.3%
Other Assets, Noncurrent 257K USD -70.1%
Assets 10.9M USD -61.8%
Accounts Payable, Current 1.1M USD -16.7%
Accrued Liabilities, Current 1.32M USD +29%
Liabilities, Current 6.56M USD -22.8%
Operating Lease, Liability, Noncurrent 423K USD -49.7%
Other Liabilities, Noncurrent 38.7K USD -95.8%
Liabilities 10.4M USD -39.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.51K USD
Retained Earnings (Accumulated Deficit) -235M USD -9.38%
Stockholders' Equity Attributable to Parent 475K USD -95.8%
Liabilities and Equity 10.9M USD -61.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.36M USD +26.5%
Net Cash Provided by (Used in) Financing Activities -1.31M USD -124%
Net Cash Provided by (Used in) Investing Activities -3.54M USD -166%
Common Stock, Shares Authorized 26.7M shares 0%
Common Stock, Shares, Issued 2.21M shares -74.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.21M USD -284%
Interest Paid, Excluding Capitalized Interest, Operating Activities 75K USD -46.4%
Operating Lease, Liability 905K USD -28.4%
Payments to Acquire Property, Plant, and Equipment 6.24K USD -25.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20.1M USD -7.17%
Lessee, Operating Lease, Liability, to be Paid 956K USD -30.4%
Property, Plant and Equipment, Gross 7.09M USD -14.4%
Operating Lease, Liability, Current 482K USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 521K USD +7.58%
Lessee, Operating Lease, Liability, to be Paid, Year One 391K USD -19.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 50.7K USD -53.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 43.4K USD +7.59%
Operating Lease, Payments 130K USD +10.5%
Additional Paid in Capital 235M USD +4.14%
Share-based Payment Arrangement, Expense 643K USD -47.9%
Interest Expense 746K USD -28.5%